Gel Permeation Chromatography (GPC) Market Growth Driven by Advanced Polymer Analysis Applications

[Divakar Kolhe]

As the pharmaceutical world shifts from small molecules to complex biologics, the Gel Permeation Chromatography GPC Market is becoming a cornerstone of drug safety.

Market Overview and Growth Snapshot

Biopharmaceutical analysis is the fastest-growing application segment, advancing at a CAGR of over 10%. This is driven by the global surge in monoclonal antibody (mAb) and gene therapy production.

Key Drivers and Market Dynamics

• Protein Aggregation Monitoring: GPC is vital for detecting protein aggregates, which can cause adverse immune responses in patients.

• Vaccine Development: The precision of GPC in characterizing viral vectors and mRNA lipid nanoparticles has become critical in post-2020 drug development.

Segmentation and Regional Insights

North America leads this segment, housing the majority of global biotech giants. However, India and China are rapidly expanding their biosimilar manufacturing capabilities, increasing GPC adoption.

Competitive Landscape and Opportunities

Companies like Waters Corporation and Agilent are developing "Biocompatible GPC" systems that use inert materials to prevent protein sticking and denaturation during analysis.

Future Outlook

Integration with Mass Spectrometry (GPC-MS) will become the standard for providing both size and sequence data in a single run.

3 FAQs

• Why is GPC used for proteins? To ensure they are the correct size and haven't formed harmful clumps (aggregates).

• Is it different from SEC? In the biotech world, GPC and SEC (Size Exclusion Chromatography) are often used interchangeably.

• Can GPC analyze mRNA? Yes, it is used to characterize the lipid nanoparticles that deliver mRNA.